Please login to the form below

Not currently logged in
Email:
Password:

Dr Reddy’s Laboratories founder passes away

Dr K. Anji Reddy loses cancer battle

Dr Reddy's Laboratories Dr K Anji ReddyDr K Anji Reddy, the founder and chairman of India's Dr Reddy's Laboratories died last week after a long battle with liver cancer.

The son of a turmeric farmer, he set up the company that bears his name in 1984 and grew the Hyderabad-based firm into one of India's leading pharmaceutical companies.

In 1993, it became the first initiate domestic firm to begin its own basic drug discovery research and, while this has yet to come to fruition, its generics business has gone from strength to strength.

His son, and current managing director of Dr Reddy's Laboratories, Satish Reddy said: “Dr Reddy touched millions of lives through his contribution to the pharmaceutical industry and his philanthropic efforts. In improving access to affordable, high quality medicines and in innovation, his contributions have been extraordinary.”

Dr K Anji Reddy was increasingly focused on philanthropy in the last 15 years, leading initiatives to provide safe rural drinking water and meals to school children and farmers.

Of late, the company has been run by his son K Satish Reddy, as managing director and COO, and his son-in-law G V Prasad, who is the vice chairman and CEO.

A BSc graduate from Bombay University with specialisation in Pharmaceutical Science and Fine Chemicals, Dr Reddy obtained his PhD in Chemical Engineering from National Chemical Laboratory, Pune.

Soon after his studies, he served in the state-owned IDPL before he founded his own company in 1984.

Dr Reddy served as a member of the Prime Minister's Council on Trade & Industry, Government of India and was honoured with one of India's highest civilian awards, the Padma Bhushan, in April 2011.

18th March 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics